Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Belloff Neil S., Chief Executive Officer. Insider active across 1 company, notably Eloxx Pharmaceuticals, Inc.. In total, 3 disclosures have been logged. Activity tracked since 30 April 2021. The latest transaction was filed on 30 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Neil S. Belloff is the Chief Operating Officer, General Counsel, and Corporate Secretary of Eloxx Pharmaceuticals, Inc. He oversees the daily operations of the company while ensuring legal and regulatory compliance. His role is crucial for navigating the complex and ever-evolving pharmaceutical sector.